Class I MHC Polymorphisms Associated with Type 2 Diabetes in the Mexican Population

Type 2 diabetes (T2D) has been linked to the expression of Human Leukocyte Antigens, principally to the Major Histocompatibility Complex Class II, with only scarce reports of Major Histocompatibility Complex Class I in specific populations. The objective of the present work was to explore the presen...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Genes 2022-04, Vol.13 (5), p.772
Hauptverfasser: Mendoza-Ramírez, Paola, López-Olaiz, Mildred Alejandra, Morales-Fernández, Adriana Lizeth, Flores-Echiveste, María Isabel, de Jesus Casillas-Navarro, Antonio, Pérez-Rodríguez, Marco Andrés, de Jesús Orozco-Luna, Felipe, Cortés-Romero, Celso, Zuñiga, Laura Yareni, Sanchez Parada, María Guadalupe, Hernandez-Ortega, Luis Daniel, Mercado-Sesma, Arieh Roldán, Baptista-Rosas, Raúl C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Type 2 diabetes (T2D) has been linked to the expression of Human Leukocyte Antigens, principally to the Major Histocompatibility Complex Class II, with only scarce reports of Major Histocompatibility Complex Class I in specific populations. The objective of the present work was to explore the presence of polymorphisms in the MHC Class I related to T2D in the Mexican population using the Genome-Wide Association Studies Slim Initiative in Genomic Medicine of the Americas (GWAS SIGMA) database. This database contains information on 3848 Mexican individuals with T2D and 4366 control individuals from the same population without a clinical or hereditary history of the disease. The searching criteria considered a p-value of 1.0. Ten novel, statistically significant nucleotide variants were identified: four polymorphisms associated with HLA-A (A*03:01:01:01) and six with HLA-C (C*01:02:01:01). These alleles have a high prevalence in Latin American populations and could potentially be associated with autoimmunity mechanisms related to the development of T2D complications.
ISSN:2073-4425
2073-4425
DOI:10.3390/genes13050772